RPHARMY
DEAD

Serial Number

88743019

Owner

RPHARMY, LLC,

Attorney

H. Artoush Ohanian

First Use Date

May 15, 2019

Filing Date

Dec 31, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RPHARMY Trademark

Serial Number: 88743019

RPHARMY is a trademark filed by RPHARMY, LLC, on December 31, 2019. The trademark is classified under Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

RPHARMY, LLC, (6 trademarks)

Austin, TX 787343975

Entity Type: 16

Trademark Details

Filing Date

December 31, 2019

Registration Date

Not Registered

First Use Anywhere

May 15, 2019

First Use in Commerce

May 15, 2019

Goods & Services

Database management in the field of pharmaceutical, clinical and management decision making, regulatory compliance of facility specific hazardous drug formulary and other health information to aid and protect healthcare providers in the preparation, dispensing and administration of hazardous drugs; documentation in the nature of recordkeeping, inventory, hazard assessment, safe handling practices, personal protective equipment, waste handling, cleaning, engineering controls, etc. in the field of pharmaceutical, clinical and management decision making, regulatory compliance of facility specific hazardous drug formulary and other health information to aid and protect healthcare providers in the preparation, dispensing and administration of hazardous drugs; calculation in the nature of recordkeeping, inventory, hazard assessment, safe handling practices, personal protective equipment, waste handling, cleaning, engineering controls, etc. in the field of pharmaceutical, clinical and management decision making, regulatory compliance of facility specific hazardous drug formulary and other health information to aid and protect healthcare providers in the preparation, dispensing and administration of hazardous drugs; appointment scheduling services in the field of pharmaceutical, clinical and management decision making, regulatory compliance of facility specific hazardous drug formulary and other health information to aid and protect healthcare providers in the preparation, dispensing and administration of hazardous drugs; communication, namely, literature, website, and mobile application in the nature of providing customized communication programs to promote the goods, services, and brands of others through all public communication means, etc. in the field of pharmaceutical, clinical and management decision making, regulatory compliance of facility specific hazardous drug formulary and other health information to aid and protect healthcare providers in the preparation, dispensing and administration of hazardous drugs; reporting in the nature of regulatory compliance reporting, preparation of business reports, statistical reporting services for business purposes, etc. in the field of pharmaceutical, clinical and management decision making, regulatory compliance of facility specific hazardous drug formulary and other health information to aid and protect healthcare providers in the preparation, dispensing and administration of hazardous drugs

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 13, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 13, 2021 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 30, 2020 GNFN
FINAL REFUSAL E-MAILED
Oct 30, 2020 GNFR
FINAL REFUSAL WRITTEN
Oct 30, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 8, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2020 NWOS
NEW APPLICATION ENTERED
Jan 3, 2020 NWAP